Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 4/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.62 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.59 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.59 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18930198 | 1.00 | CYP3A4 (0.62) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL18462608 | 0.94 | CYP3A4 (0.53) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL18930051 | 0.94 | CYP3A4 (0.62) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL13291733 | 0.94 | CYP3A4 (0.71) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL203257 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL9605175 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL18462725 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL2707197 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL204882 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 | |
| SCHEMBL18925880 | 0.93 | CYP3A4 (0.70) | CYP3A4CYP2C9NR1I2ABCB11OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9586978-B2 | Anti-viral compounds | ABBVIE INC. (US) | 2017-03-07 | — | — | US | disclosed |